Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate

被引:31
|
作者
Innocenti, A [1 ]
Vullo, D [1 ]
Scozzafava, A [1 ]
Supuran, CT [1 ]
机构
[1] Univ Florence, Chim Bioorgan Lab, I-50019 Sesto Fiorentino, Firenze, Italy
关键词
D O I
10.1016/j.bmcl.2004.11.056
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The inhibition of five human carbonic anhydrase (hCA, EC 4.2.1.1) isozymes; the cytosolic hCA I and II, the membrane-bound hCA IV. the mitochondrial hCA V, and the tumor-associated, transmembrane hCA IX, with anions isosteric and isoelectronic with sulfate, nitrate, and carbonate; such as chlorate, perchlorate, bromate, iodate, periodate, silicate, bismuthate, vanadate, molybdate, and wolframate is reported. Apparently, the geometry of the inhibitor (tetrahedral or trigonal) does not influence its binding to the Zn(II) ion of the enzyme active site, but the nature of the central element is the most important factor influencing potency. Isozymes hCA I and II are best inhibited by chlorate, perchlorate, and silicate, together with the anions structurally related to sulfate, sulfamate, and sulfamidate, but sulfate itself is a weak inhibitor (inhibition constant of 74 mM against hCA I and 183 mM against hCA II). Molybdate is a very weak hCA I inhibitor (K-I of 914 mM) but it interacts with hCA II (K-I of 27.5 mM). Isozyme IV is well inhibited by sulfate (K-I of 9 mM), sulfamate, and sulfamidate (in the low micromolar range), but not by perchlorate (KI of 767 mM). The mitochondrial isozyme V has the lowest affinity for sulfate (KI of 680 mM) and carbonate (K-I of 95 mM) among all the investigated isozymes, suggesting on one hand its possible participation in metabolon(s) with sulfate anion exchanger(s), and on the other hand an evolutionary adaptation to working at higher pH values (around 8.5 in mitochondria) where rather high amounts of carbonate in equilibrium with bicarbonate may be present. Metasilicate, isosteric to carbonate, is also about a 10 times weaker inhibitor of this isozyme as compared to other CAs investigated here (K-I of 28.2 mM). Surprisingly, the tumor-associated isozyme IX is resistant to sulfate inhibition (K-I of 154 mM) but has affinity in the low micromolar range for carbonate, sulfamate, and sulfamidate (K-I in the range of 8.6-9.6 muM). This constitutes another proof that this isozyme best works at acidic pH values present in tumors, being inhibited substantially at higher pH values when more carbonate may be present. Bromate and chlorate are quite weak CA IX inhibitors (KI s of 147-274 mM). (C) 2004 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:567 / 571
页数:5
相关论文
共 50 条
  • [1] Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates
    Innocenti, A
    Vullo, D
    Scozzafava, A
    Casey, JR
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 573 - 578
  • [2] Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V and IX with complex fluorides, chlorides and cyanides
    Innocenti, A
    Antel, J
    Wurl, M
    Vullo, D
    Firnges, MA
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (07) : 1909 - 1913
  • [3] Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with organic phosphates and phosphonates
    Winum, JY
    Innocenti, A
    Gagnard, V
    Montero, JL
    Scozzafava, A
    Vullo, D
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) : 1683 - 1686
  • [4] Carbonic anhydrase inhibitors. Part 87 - Inhibition of carbonic anhydrase isozymes I, II and IV with arsinolipids
    Ioannou, PV
    Kordalis, NL
    Scozzafava, A
    Supuran, CT
    MAIN GROUP METAL CHEMISTRY, 1999, 22 (12) : 693 - 695
  • [5] Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with anions
    Vullo, D
    Franchi, M
    Gallori, E
    Pastorek, J
    Scozzafava, A
    Pastorekova, S
    Supuran, CT
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2003, 18 (05) : 403 - 406
  • [6] Carbonic anhydrase inhibitors.: Part 591 inhibition of carbonic anhydrase isozymes I, II and IV with arsanilic acid derivatives
    Scozzafava, A
    Briganti, F
    Supuran, CT
    MAIN GROUP METAL CHEMISTRY, 1998, 21 (06): : 357 - 364
  • [7] Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with phosphates, carbamoyl phosphate, and the phosphonate antiviral drug foscarnet
    Rusconi, S
    Innocenti, A
    Vullo, D
    Mastrolorenzo, A
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (23) : 5763 - 5767
  • [8] Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides
    Franchi, M
    Vullo, D
    Gallori, E
    Pastorek, J
    Russo, A
    Scozzafava, A
    Pastorekova, S
    Supuran, CT
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2003, 18 (04) : 333 - 338
  • [9] Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols
    Senturk, Murat
    Gulcin, Ilhami
    Dastan, Arif
    Kufrevioglu, O. Irfan
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (08) : 3207 - 3211
  • [10] Carbonic anhydrase inhibitors: Inhibition of human and murine mitochondrial isozymes V with anions
    Franchi, M
    Vullo, D
    Gallori, E
    Antel, J
    Wurl, M
    Scozzafava, A
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (17) : 2857 - 2861